RANDY H THURMAN
CIK 1204059 · Executive Chairman · last filed 2026-05-27
RANDY H THURMAN is an Executive Chairman who has filed 56 SEC Form 4 insider transactions across 10 companies since 2007. The most recent filing shows the insider bought $2.1K of OTLK on May 27, 2026. Across all open-market trades the lifetime net is −$393.9K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $2.2M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$2.21M
10
56
-$393.9K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| OTLK | Director | 5,593 | $1.22 | $6.8K | $2.1K | 6 | 2026-05-27 |
| TFF Pharmaceuticals, Inc. (TFFP) Delisted | Director | 0 | $0.07 | $0 | -$772.6K | 6 | 2022-09-30 |
| Outlook Therapeutics, Inc. (OTLKW) Delisted | Director | 11,875 | $0.03 | $356 | $16.5K | 8 | 2021-03-26 |
| Outlook Therapeutics, Inc. (ONSIW) Delisted | Director | — | — | — | $0 | 3 | 2018-11-13 |
| Outlook Therapeutics, Inc. (ONSIZ) Delisted | Director | — | — | — | $0 | 1 | 2018-04-17 |
| Veradigm Inc. (MDRX) Delisted | Director | 105,014 | $6.81 | $715.1K | $150.8K | 7 | 2017-05-24 |
| LENS | Executive Chairman | 47,757 | $41.84 | $2.00M | $109.5K | 6 | 2017-03-22 |
| OFIX | Director | — | $9.31 | — | $0 | 1 | 2013-11-21 |
| BEAT | Chairman, President & CEO | 264,766 | $0.76 | $200.6K | $99.8K | 10 | 2011-05-03 |
| VIASYS HEALTHCARE INC (VAS) Delisted | Chairman, President & CEO | 51,334 | — | — | $0 | 3 | 2007-06-25 |
Recent Filings
56 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-05-27 | OTLK | Buy (P) | +5,000 | $2.1K | EDGAR |
| 2025-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-10-03 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2024-03-08 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2023-03-31 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2022-09-30 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Mixed | — | -$72.1K | EDGAR |
| 2022-03-24 | OTLK | Grant (A) | — | $0 | EDGAR |
| 2021-05-19 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Buy (P) | +1,050 | $9.9K | EDGAR |
| 2021-03-26 | Outlook Therapeutics, Inc. (OTLKW) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-11-13 | TFF Pharmaceuticals, Inc. (TFFP) Delisted | Mixed | −5,000 | -$548.5K | EDGAR |